Pharmacokinetics of praziquantel in healthy volunteers and patients with schistosomiasis.

[1]  A. Fenwick,et al.  EFFECT OF ANTISCHISTOSOMAL CHEMOTHERAPY ON PREVALENCE OF SYMMERS' PERIPORTAL FIBROSIS IN SUDANESE VILLAGES , 1988, The Lancet.

[2]  O. P. Shukla,et al.  Altered drug metabolism in parasitic diseases. , 1988, Parasitology today.

[3]  T. Nash,et al.  Diagnosis of pathologically confirmed Symmers' periportal fibrosis by ultrasonography: a prospective blinded study. , 1988, The American journal of tropical medicine and hygiene.

[4]  J. R. Cançado,et al.  Therapeutical evaluation of different dose regimens of praziquantel in schistosomiasis mansoni, based on the quantitative oogram technique. , 1987, Revista do Instituto de Medicina Tropical de Sao Paulo.

[5]  D. Harron,et al.  Propranolol disposition in patients with hepatosplenic schistosomiasis. , 1987, British journal of clinical pharmacology.

[6]  T. Walle,et al.  Increased clearance of propranolol and theophylline by high‐protein compared with high‐carbohydrate diet , 1987, Clinical pharmacology and therapeutics.

[7]  S. Sulaiman,et al.  Oltipraz: administration with food increases its anti-schistosomal activity. , 1986, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[8]  D. Back,et al.  The pharmacokinetics of antipyrine in patients with graded severity of schistosomiasis. , 1985, British journal of clinical pharmacology.

[9]  R. Spector,et al.  The effect of dietary protein on the clearance of allopurinol and oxypurinol. , 1985, The New England journal of medicine.

[10]  E. Aa The Blue Nile Health Project: a comprehensive approach to the prevention and control of water-associated diseases in irrigated schemes of the Sudan. , 1985, The Journal of tropical medicine and hygiene.

[11]  T. Nash,et al.  Schistosome infections in humans: perspectives and recent findings. NIH conference. , 1982, Annals of internal medicine.

[12]  H. Frohberg,et al.  Toxicological profile of praziquantel, a new drug against cestode and schistosome infections, as compared to some other schistosomicides. , 1981, Arzneimittel-Forschung.

[13]  P. Jordan,et al.  Schistosomiasis transmission with particular reference to possible ecological and biological methods of control. A review. , 1980, Acta tropica.

[14]  A. Conney,et al.  Nutrition and oxidative drug metabolism in man: Relative influence of dietary lipids, carbohydrate, and protein , 1979, Clinical pharmacology and therapeutics.

[15]  A. Prata,et al.  Altered drug metabolism in hepatosplenic schistosomiasis. , 1979, Revista do Instituto de Medicina Tropical de Sao Paulo.

[16]  K. Warren,et al.  Control of schistosomiasis: report of a workshop. , 1979, The American journal of tropical medicine and hygiene.

[17]  E. Vesell,et al.  Unaltered metabolism of antipyrine and tolbutamide in fasting man , 1975, Clinical pharmacology and therapeutics.